Clinical Trial 40229

Long Beach, CA 90806


Summary:

A Prospective, Randomized, Double-Blind, Dose-Comparison Concurrent Control Study to Assess the Safety and Tolerability of GRF6019 Infusions in Subjects with Mild to Moderate Alzheimer’s Disease


Qualified Participants Must:

• Male or female, aged 60-90 years
• Diagnosis of probable Alzheimer's Disease


Qualified Participants May Receive:

Compensation for time and travel 


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.